Back to Dividend Stocks
Arcus Biosciences Inc. (RCUS) logo

Arcus Biosciences Inc.

S&P 500

RCUS/Healthcare · Biotechnology/NYSE

Stock Price

$30.25

Stock Price$30.25MCap3.4BLast update: Jun 26, 2026 at 06:56

Dividend Safety Rating

N/A/ 100

RCUS does not currently pay a dividend. The Dividend Safety Rating is not applicable for non-dividend stocks.

About Arcus Biosciences Inc.

Arcus Biosciences Inc. is a biopharmaceutical company dedicated to developing innovative cancer therapies. Focusing primarily on immuno-oncology, the company aims to harness the body's own immune system to target and eliminate cancer cells. Arcus Biosciences' pipeline includes a variety of monoclonal antibodies, small molecules, and combination therapies that address different aspects of cancer's complex biology. One of its core strategies is to develop next-generation treatments that can potentially improve upon existing therapies, enhancing efficacy while minimizing side effects. Operating in an industry marked by rapid scientific advancements, Arcus Biosciences plays a critical role in the ongoing pursuit of more effective cancer treatments. Its efforts contribute to the diversification of therapeutic options available to clinicians, offering hope to patients managing the challenges of cancer. Through strategic partnerships and robust research initiatives, Arcus Biosciences continues to expand its impact within the highly competitive biopharmaceutical sector, underscoring the importance of innovation in the battle against cancer.

Dividend Overview

Dividend Yield

0.00%

Annual Dividend

$0.00

Frequency

N/A

Payout Ratio

0.00%

FCF Payout Ratio

0.00%

52-Week Range

$7.91 - $31.44

Earnings & Profitability

RCUS earnings per share and net profit margin

Key Dates

Next Ex-Dividend Date

Next Payment Date

Dividend Growth

3-Year Dividend CAGR

N/A

5-Year Dividend CAGR

N/A

10-Year Dividend CAGR

N/A

3-Year Total Growth

N/A

5-Year Total Growth

N/A

10-Year Total Growth

N/A

Income Calculator

RCUS Dividend Calculator

Total Investment

$3,025.00

Annual Income

$0.00

Quarterly Income

$0.00

Monthly Income

$0.00

Frequently Asked Questions

What is RCUS's current dividend yield?
Arcus Biosciences Inc. (RCUS) currently has a dividend yield of 0.00%, based on a stock price of $30.25 and an annual dividend of $0.00.
When is RCUS's next dividend payment date?
RCUS's next ex-dividend date is — and the next payment date is —. You must own the stock before the ex-dividend date to receive the upcoming payment.
How much does RCUS pay in dividends per year?
Arcus Biosciences Inc. pays dividends unknown. Annual dividend data is not yet available.
Has RCUS been increasing its dividend?
Arcus Biosciences Inc. has grown its dividend at a 5-year CAGR of —.
Is RCUS's dividend safe?
Arcus Biosciences Inc. has a payout ratio of 0.00%. Its free cash flow payout ratio is 0.00%. A payout ratio below 60% is generally considered sustainable.
How is RCUS's Dividend Safety Rating calculated?
The Dividend Safety Rating evaluates Arcus Biosciences Inc.'s dividend sustainability across four categories: Payout & Coverage (30%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (30%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track RCUS Dividends with OnlyDividends

What will RCUS actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

Download the App

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.